The DentaCell Accelerator

powered by Leonhardt’s Launchpads
and Cal-X Stars Business Accelerator, Inc.

is a collaboration to help today’s dentistry technology innovators turn their ideas into breakthroughs that can improve the lives of patients around the world.

About the Program

Companies selected for the DentaCell Accelerator powered by Leonhardt’s Launchpads will have access to the world’s leading dentistry physicians, stem cell & bioelectric regeneration researchers and experience startup building mentors to help advance breakthrough innovations in dentistry.

About DentaCell Accelerator:  Originally founded in 2015 as DentaCell LTP focused on bioelectric and stem cell based dental products including tooth pulp storage services.  In 2017 DentaCell LTP was converted into an accelerator to enable the organization to more broadly address innovations in dentistry and to better support multiple startup launches simultaneously.

Companies Receive

  • Access to office and lab space located in Los Angeles, Petaluma and Salt Lake City.
  • Access to all the startup support programs, legal agreement templates, outlines from Leonhardt’s Launchpads, Kindheart Lionheart Startup Support Services – and Cal-X Crowdfund Connect –
  • Free enrollment in the Santa Monica based CalXelerator “108 Days from Create to Great” startup launch program – a minimum investment of $8K per founder up to $1 million.
  • Access to Leonhardt’s Launchpad’s building IP estate in stem cell, growth factors, micro pumps and bioelectric stimulation technologies.
  • Mentorship from physicians, researchers, regulatory experts, legal counsel and startup specialists.
  • Access to Leonhardt’s Launchpad’s and Cal-X Stars Business Accelerator, Inc. network of hundreds of successful entrepreneurs, investors, mentors, and corporate partners.
  • Annual Demo Days, where each company will have the opportunity to pitch their company to healthcare leaders, investors, press, and other community members.

“The era of dental treatment with more natural approaches with living cells and bioelectric signaling, all personalized to the individual patient, has arrived and we are excited to helping to lead the way.”

Dr. Valerie Kanter

Chief Medical & Scientific Officer

Contact Us

14 + 9 =

CAUTION Disclaimer and Warning: Products described on this web site are in early stage development and are not yet proven safe or effective in statistically significant controlled clinical studies. Any statement or phrases implying efficacy or safety in any form are considered modified by “intended to” or “designed to”. Investigational use only in countries where investigation is permitted by law and proper filings have been made and appropriate regulatory clearances have been granted. Any use of the product(s) must be in an authorized clinical study with institutional review board (ethics committee) approval and proper patient consent procedures followed. For other countries product is only available for laboratory investigation by credentialed institutions and investigators with proper clearances with a research agreement in place with a study sponsor. NOT AVAILABLE FOR SALE.